Lipid-Induced Insulin Resistance in Skeletal Muscle: The Chase for the Culprit Goes from Total Intramuscular Fat to Lipid Intermediates, and Finally to Species of Lipid Intermediates
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
The skeletal muscle is the largest organ in the body. It plays a particularly pivotal role in glucose homeostasis, as it can account for up to 40% of the body and for up to 80%–90% of insulin-stimulated glucose disposal. Hence, insulin resistance (IR) in skeletal muscle has been a focus of much research and review. The fact that skeletal muscle IR precedes β-cell dysfunction makes it an ideal target for countering the diabetes epidemic. It is generally accepted that the accumulation of lipids in the skeletal muscle, due to dietary lipid oversupply, is closely linked with IR. Our understanding of this link between intramyocellular lipids (IMCL) and glycemic control has changed over the years. Initially, skeletal muscle IR was related to total IMCL. The inconsistencies in this explanation led to the discovery that particular lipid intermediates are more important than total IMCL. The two most commonly cited lipid intermediates for causing skeletal muscle IR are ceramides and diacylglycerol (DAG) in IMCL. Still, not all cases of IR and dysfunction in glycemic control have shown an increase in either or both of these lipids. In this review, we will summarise the latest research results that, using the lipidomics approach, have elucidated DAG and ceramide species that are involved in skeletal muscle IR in animal models and human subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic representation of the insulin signalling pathway with years of discovery of the key elements in the pathway. Numbers in superscript are reference list numbers [8,9,10,11,12,13,14,15,16].](https://figures.cochat.ai/paper-figures/9eec8ecd21b3453cb86ac222fc17c241/lipid-induced-insulin-resistance-in-skeletal-muscle-the-chase-for-the-culprit-figure-1.jpg)
![Figure 2 A brief schematic display of the interconversions of ceramide and other sphingolipids. Adapted from Hannun and Obeid [52]. Full enzymatic details can be found elsewhere [52].](https://figures.cochat.ai/paper-figures/b246fef02d404e3b8e8832e2f4c1b361/lipid-induced-insulin-resistance-in-skeletal-muscle-the-chase-for-the-culprit-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Activated macrophages release TNF-α, IL-1b, IL-6, and TGF-β, which stimulate myofibroblasts, increase collagen production, and decrease protease inhibitor secretion [121,122].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [122]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · cited 4×
“The seminal paper by Reaven [3] also indicated that resistance to insulin-stimulated glucose uptake was observed in 25% of non-obese individuals with normal oral glucose tolerance.”
BackgroundInfluentialPrinciples of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333 · cited 10×
“It is even suggested that there is a need for separate “omics” for sphingolipids–sphingolipidome [52,55].”
BackgroundInfluentialMechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102 · cited 2×
“Skeletal muscle IR is thus considered the initiating or primary defect [7] that can be detected decades ahead of the β-cell failure and hyperglycaemia.”
BackgroundFranke, T. F., Yang, S.-I., Chan, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., Kaplan, D. R., & Tsichlis, P. N. (1995) · Cell · doi:10.1016/0092-8674(95)90534-0 · Cited by 2,006
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · cited 1×
“[41] reported changes in protein kinase C- theta (PKC-θ) as a result of increased DAG accumulation following lipid infusion in male Wistar rats.”
BackgroundItani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
PGC-1α: a key regulator of energy metabolism
Liang, H., & Ward, W. F. (2006) · Advances in Physiology Education · doi:10.1152/advan.00052.2006 · Cited by 1,245
Holland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232
Goodpaster, B. H. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5755 · Cited by 1,194 · cited 1×
“[36] were the first to report an increase in intramyocellular lipid in endurance athletes without consequent impaired glycemic control, which they termed “Athlete’s Paradox”.”
BackgroundLipid-induced insulin resistance: unravelling the mechanism
Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60408-4 · Cited by 1,189 · cited 3×
“driver of lipid-induced insulin resistance in the skeletal muscle [4,5,27].”
BackgroundLipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100 · cited 2×
“The connection between ectopic accumulation of lipids and impaired glycemic control was widely known before Unger [38] coined the term lipotoxicity.”
BackgroundWarram, J. H., Martin, B. C., Krolewski, A. S., Soeldner, J. S., & Kahn, C. R. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-909 · Cited by 1,038 · cited 2×
“Other auth rs also not IR as the principal feature of T2DM that can precede its clinical manifestation by 10–20 y rs [6].”
BackgroundInsulin-stimulated Phosphorylation of a Rab GTPase-activating Protein Regulates GLUT4 Translocation
Sano, H., Kane, S., Sano, E., Mı̂inea, C. P., Asara, J. M., Lane, W. S., Garner, C. W., & Lienhard, G. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300063200 · Cited by 962
Whitman, M., Kaplan, D. R., Schaffhausen, B., Cantley, L., & Roberts, T. M. (1985) · Nature · doi:10.1038/315239a0 · Cited by 810
Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
Merrill, A. H. (2011) · Chemical Reviews · doi:10.1021/cr2002917 · Cited by 785 · cited 4×
“Sphingolipid metabolism is very complex and there are estimated to be 4000 to 60,000 sphingolipid mediators [55].”
BackgroundInfluentialThe internal secretion of the pancreas
Banting, F., & BEST, C. H. (1922) · Journal of Laboratory and Clinical Medicine · doi:10.5555/uri:pii:s0022214322903841 · Cited by 784
Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth
Jo, J., Gavrilova, O., Pack, S., Jou, W., Mullen, S., Sumner, A. E., Cushman, S. W., & Periwal, V. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000324 · Cited by 774 · cited 1×
“When there is dietary lipid oversupply, the body responds by increasing the number and size of adipocytes [35]—the normal storage sites for excess fat.”
BackgroundGlatz, J. F. C., Luiken, J. J. F. P., & Bonen, A. (2010) · Physiological Reviews · doi:10.1152/physrev.00003.2009 · Cited by 751 · cited 7×
“The location and activities of each of this FATP has been elucidated using specific knockout models.”
BackgroundInfluentialAlessi, D. R., Deak, M., Casamayor, A., Barry Caudwell, F., Morrice, N., Norman, D. G., Gaffney, P., Reese, C. B., MacDougall, C. N., Harbison, D., et al. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00336-8 · Cited by 737
Aitman, T. J., Glazier, A. M., Wallace, C. A., Cooper, L. D., Norsworthy, P. J., Wahid, F. N., Al-Majali, K. M., Trembling, P. M., Mann, C. J., Shoulders, C. C., et al. (1999) · Nature Genetics · doi:10.1038/5013 · Cited by 735 · cited 1×
“[25], CD36 is the most commonly studied fatty acid carrier in skeletal muscle.”
BackgroundTakai, Y., Kishimoto, A., Kikkawa, U., Mori, T., & Nishizuka, Y. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91197-5 · Cited by 731 · cited 1×
“[49] suggested that unsaturated diacylglycerol is a possible messenger for the activation of calcium-activated, phospholipid-dependent protein kinase system.”
BackgroundHolland, W. L., Bikman, B. T., Wang, L.-P., Yuguang, G., Sargent, K. M., Bulchand, S., Knotts, T. A., Shui, G., Clegg, D. J., Wenk, M. R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43378 · Cited by 705
Turpin, S. M., Nicholls, H. T., Willmes, D. M., Mourier, A., Brodesser, S., Wunderlich, C. M., Mauer, J., Xu, E., Hammerschmidt, P., Brönneke, H. S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.002 · Cited by 691 · cited 1×
“In 2014, two animal model studies [69,70] were published identifying C16:0 ceramide as the sphingolipid that mediates the pathophysiology of IR in liver.”
BackgroundInsulin-regulatable tissues express a unique insulin-sensitive glucose transport protein
James, D. E., Brown, R., Navarro, J., & Pilch, P. F. (1988) · Nature · doi:10.1038/333183a0 · Cited by 666
Ceramides – Lipotoxic Inducers of Metabolic Disorders
Chaurasia, B., & Summers, S. A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.07.006 · Cited by 616 · cited 11×
“The effectors for this stimulation are protein phosphatase 2A (PP2A) and PKC-zeta (PKC-ζ) [62].”
BackgroundInfluentialA Ceramide-Centric View of Insulin Resistance
Chavez, J. A., & Summers, S. A. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.002 · Cited by 610
Holland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 595
Freychet, P., Roth, J., & Neville, D. M. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.8.1833 · Cited by 498
Diacylglycerol-mediated insulin resistance
Erion, D. M., & Shulman, G. I. (2010) · Nature Medicine · doi:10.1038/nm0410-400 · Cited by 489 · cited 3×
“The mechanism proposed for DAG-induced IR is as follows [40]: increased plasma FA concentration leads to accumulation of intramyocellular acyl CoAs and DAG, which activates isoforms of protein kinase C (PKC), which, in turn, decrease the activities of PI3K and ISR-1 in the insulin signalling pathway for muscle glucose…”
BackgroundRaichur, S., Wang, S. T., Chan, P. W., Li, Y., Ching, J., Chaurasia, B., Dogra, S., Öhman, M. K., Takeda, K., Sugii, S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.015 · Cited by 455 · cited 1×
“In 2014, two animal model studies [69,70] were published identifying C16:0 ceramide as the sphingolipid that mediates the pathophysiology of IR in liver.”
BackgroundTurner, N., Kowalski, G. M., Leslie, S. J., Risis, S., Yang, C., Lee-Young, R. S., Babb, J. R., Meikle, P. J., Lancaster, G. I., Henstridge, D. C., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2913-1 · Cited by 430 · cited 2×
“’s [51] work showed, high-fat diet induced loss of glycemic control can manifest itself within days without sufficient time for change in muscle lipid profile.”
BackgroundRole of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans
Szendroedi, J., Yoshimura, T., Phielix, E., Koliaki, C., Marcucci, M., Zhang, D., Jelenik, T., Müller, J., Herder, C., Nowotny, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409229111 · Cited by 415 · cited 1×
“[47] reported that DAG species that contained C16:0, C18:0, C18:1, C18:2 or C20:4 FA showed the strongest relationship with PKC-θ activation and IR in obese and T2DM individuals.”
BackgroundLipoapoptosis in Beta-cells of Obese Prediabeticfa/fa Rats
Shimabukuro, M., Higa, M., Zhou, Y.-T., Wang, M.-Y., Newgard, C. B., & Unger, R. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32487 · Cited by 395 · cited 2×
“The initial confirmation of this hypothesis was achieved using pharmacological inhibitors of de novo ceramide synthesis in prediabetic obese rats [64].”
BackgroundRaichur, S., Wang, S. T., Chan, P. W., Li, Y., Ching, J., Chaurasia, B., Dogra, S., Öhman, M. K., Takeda, K., Sugii, S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.007 · Cited by 385
Dubé, J. J., Amati, F., Stefanovic-Racic, M., Toledo, F. G. S., Sauers, S. E., & Goodpaster, B. H. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00769.2007 · Cited by 378 · cited 2×
“Interestingly, Goodpaster’s group [37] found significant correlation between decrease in muscle ceramide content and increase in insulin sensitivity; but they did not find a correlation between decrease in muscle DAG and insulin sensitivity.”
BackgroundEditorial (Thematic Issue: Mitochondrial Biogenesis: Pharmacological Approaches)
Valero, T. (2014) · Current Pharmaceutical Design · doi:10.2174/138161282035140911142118 · Cited by 367 · cited 1×
“Thus, mitochondrial biogenesis, a process by which cells increase their individual mitochondrial mass [30] to increase oxidative capacity in relation to stimuli, has assumed importance as a viable target for pharmaceutical approaches [31].”
BackgroundRegulation of plasma free fatty acid turnover
Armstrong, D. T., Steele, R., Altszuler, N., Dunn, A., Bishop, J. S., & De Bodo, R. C. (1961) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1961.201.1.9 · Cited by 331 · cited 1×
“With respect to movement of fatty acids into muscle cells, it was initially thought that the movement of free fatty acids (FFA) from plasma into cells was through passive diffusion based on concentration gradient [19,20].”
BackgroundLee, J. S., Pinnamaneni, S. K., Eo, S. J., Cho, I. H., Pyo, J. H., Kim, C. K., Sinclair, A. J., Febbraio, M. A., & Watt, M. J. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01438.2005 · Cited by 325 · cited 2×
“7% fat Muscle DAG: (SFA = PUFA) > Control HOMA-IR: SFA > Control PUFA < Control [53] High SFA: 52.”
BackgroundRANDLE, P. J. (1986) · Biochemical Society Transactions · doi:10.1042/bst0140799 · Cited by 311 · cited 1×
“Muscle is considered a metabolically flexible [17] or promiscuous [18] organ because of its capacity to use both glucose and fatty acids as fuels.”
BackgroundFatty acid transport proteins, implications in physiology and disease
Kazantzis, M., & Stahl, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.010 · Cited by 276 · cited 4×
“A brief summary from Kazantzis and Stahl [24] is presented in Table 1.”
BackgroundInfluentialThe Role of Gut Microbiota on Insulin Resistance
Caricilli, A., & Saad, M. (2013) · Nutrients · doi:10.3390/nu5030829 · Cited by 274
Dubé, J. J., Amati, F., Toledo, F. G. S., Stefanovic-Racic, M., Rossi, A., Coen, P., & Goodpaster, B. H. (2011) · Diabetologia · doi:10.1007/s00125-011-2065-0 · Cited by 271 · cited 1×
“[68] are of particular note because they were based on skeletal muscle samples from human subjects.”
BackgroundThe New Elements of Insulin Signaling: Insulin Receptor Substrate-1 and Proteins With SH2 Domains
Myers, M. G., & White, M. F. (1993) · Diabetes · doi:10.2337/diab.42.5.643 · Cited by 229
Fatty acid metabolism, energy expenditure and insulin resistance in muscle
Turner, N., Cooney, G. J., Kraegen, E. W., & Bruce, C. R. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0397 · Cited by 196 · cited 3×
“driver of lipid-induced insulin resistance in the skeletal muscle [4,5,27].”
BackgroundEthnicity, type 2 diabetes & migrant Asian Indians.
Abate, N., & Chandalia, M. (2007) · PubMed · Cited by 181
Ceramides and Glucosylceramides Are Independent Antagonists of Insulin Signaling
Chavez, J. A., Siddique, M. M., Wang, S. T., Ching, J., Shayman, J. A., & Summers, S. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.522847 · Cited by 157
Kiens, B., Kristiansen, S., Jensen, P. B., Richter, E. A., & Turcotte, L. P. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6118 · Cited by 155 · cited 1×
“Later, saturation kinetics studies [21] pointed to the presence of fatty acid carrier proteins [22].”
BackgroundDihydroceramides: From Bit Players to Lead Actors
Siddique, M. M., Li, Y., Chaurasia, B., Kaddai, V., & Summers, S. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.653204 · Cited by 150
Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans
Bergman, B. C., Brozinick, J. T., Strauss, A., Bacon, S., Kerege, A., Bui, H. H., Sanders, P., Siddall, P., Wei, T., Thomas, M. K., et al. (2016) · Diabetologia · doi:10.1007/s00125-015-3850-y · Cited by 148
Sphingolipids and insulin resistance: the five Ws
Summers, S. A. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283373b66 · Cited by 136
Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity
Skovbro, M., Baranowski, M., Skov-Jensen, C., Flint, A., Dela, F., Górski, J., & Helge, J. W. (2008) · Diabetologia · doi:10.1007/s00125-008-1014-z · Cited by 133
Changes in fatty acid transport and transporters are related to the severity of insulin deficiency
Luiken, J. J. F. P., Arumugam, Y., Bell, R. C., Calles-Escandón, J., Tandon, N. N., Glatz, J. F. C., & Bonen, A. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00011.2002 · Cited by 126
Kasumov, T., Solomon, T. P. J., Hwang, C. E., Huang, H., Haus, J. M., Zhang, R., & Kirwan, J. P. (2015) · Obesity · doi:10.1002/oby.21117 · Cited by 125
Selathurai, A., Kowalski, G. M., Burch, M. L., Sepulveda, P. V., Risis, S., Lee, R. S., Lamon, S., Meikle, P. J., Genders, A. J., McGee, S. L., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.001 · Cited by 116 · cited 2×
“[46], where a 200% increase in muscle DAG (Table 3) following muscle-specific knockout of phosphoethanolamine cytidylytransferase (ECT) failed to induce insulin resistance in the KO mice.”
BackgroundKampmann, U., Christensen, B., Nielsen, T. S., Pedersen, S. B., Ørskov, L., Lund, S. A., Møller, N., & Jessen, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027854 · Cited by 112 · cited 1×
“On the contrary, there is less expression of GLUT4 in PM [28], with consequent reduced glucose uptake by the skeletal muscle, and development of chronic high blood glucose (hyperglycaemia).”
BackgroundTurnover rate of plasma FFA in humans and in dogs
Issekutz, B., Jr., Bortz, W. M., Miller, H. I., & Paul, P. (1967) · Metabolism · doi:10.1016/0026-0495(67)90093-5 · Cited by 107 · cited 1×
“With respect to movement of fatty acids into muscle cells, it was initially thought that the movement of free fatty acids (FFA) from plasma into cells was through passive diffusion based on concentration gradient [19,20].”
BackgroundSaturation kinetics of palmitate uptake in perfused skeletal muscle
Turcotte, L. P., Kiens, B., & Richter, E. A. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80180-b · Cited by 103 · cited 1×
“Later, saturation kinetics studies [21] pointed to the presence of fatty acid carrier proteins [22].”
BackgroundMcFarlan, J. T., Yoshida, Y., Jain, S. S., Han, X.-X., Snook, L. A., Lally, J., Smith, B. K., Glatz, J. F. C., Luiken, J. J. F. P., Sayer, R. A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.315358 · Cited by 98 · cited 1×
“Muscle is considered a metabolically flexible [17] or promiscuous [18] organ because of its capacity to use both glucose and fatty acids as fuels.”
BackgroundMetabolic roles of PGC-1α and its implications for type 2 diabetes
Besseiche, A., Riveline, J., Gautier, J., Bréant, B., & Blondeau, B. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.02.002 · Cited by 96 · cited 1×
“Recent reviews of the PGC family and mitochondrial biogenesis in relation to insulin resistance are available elsewhere [32,33].”
BackgroundMuscle mitochondria and insulin resistance: a human perspective
Hoeks, J., & Schrauwen, P. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.05.007 · Cited by 94 · cited 1×
“For instance, Hoeks and Schrauwen [34] suggested that mitochondrial dysfunction (failure to mitigate accumulation of fat in skeletal muscle) is secondary to IR rather than a causative factor for IR genesis.”
BackgroundWatson, M. L., Coghlan, M., & Hundal, H. S. (2009) · Biochemical Journal · doi:10.1042/bj20081149 · Cited by 93 · cited 1×
“Myriocin has been the commonly used agent to block ceramide synthesis in skeletal muscle [65] and other tissues.”
BackgroundLipid-mediated muscle insulin resistance: different fat, different pathways?
Ritter, O., Jelenik, T., & Roden, M. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1310-2 · Cited by 74 · cited 1×
“[48] who also suggested both the DAG species and its subcellular localisation (cytosol versus membrane) are important considerations with regards to PKC-θ activation by DAG.”
BackgroundInoue, M., Kishimoto, A., Takai, Y., & Nishizuka, Y. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33320-3 · Cited by 65
Lam, Y. Y., Hatzinikolas, G., Weir, J. M., Janovská, A., McAinch, A. J., Game, P. A., Meikle, P. J., & Wittert, G. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.04.011 · Cited by 61
Revisiting the diacylglycerol-induced insulin resistance hypothesis
Amati, F. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01036.x · Cited by 59 · cited 1×
“The lipotoxicity (lipid metabolite) theory of IR essentially refers to excess inflow of FA into the skeletal muscle that overwhelms the use of FA in skeletal muscle for β-oxidation and triacylglycerol synthesis, leading to entry of excess FA into harmful non-oxidative pathways [39].”
BackgroundDiscovery and Prospect of Protein Kinase C Research: Epilogue
Nishizuka, Y. (2003) · The Journal of Biochemistry · doi:10.1093/jb/mvg035 · Cited by 49 · cited 1×
“The debate on diacylglycerol as a physiological mediator of hormone action through the PKC system seems to have come a full circle since the initial work by Nishizuka [50].”
BackgroundRole of PKCδ in Insulin Sensitivity and Skeletal Muscle Metabolism
Li, M., Vienberg, S. G., Bézy, O., O'Neill, B. T., & Kahn, C. R. (2015) · Diabetes · doi:10.2337/db14-1891 · Cited by 44 · cited 1×
“[44] conducted an in-depth study of PKC-δ in mice that had undergone muscle-specific deletion of PKC-δ.”
BackgroundSkeletal muscle ceramide species in men with abdominal obesity
de la Maza, M. P., Rodriguez, J. M., Hirsch, S., Leiva, L., Barrera, G., & Bunout, D. C. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0548-7 · Cited by 41 · cited 1×
“[72], who found strong association between ceramide species, not total IMCL ceramide, and glucose intolerance when comparing male volunteers of contrasting BMI (BMI < 25 versus BMI > 25).”
BackgroundTargeting Mitochondrial Biogenesis to Treat Insulin Resistance
Zamora, M., & Villena, J. A. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140306102514 · Cited by 39 · cited 1×
“Thus, mitochondrial biogenesis, a process by which cells increase their individual mitochondrial mass [30] to increase oxidative capacity in relation to stimuli, has assumed importance as a viable target for pharmaceutical approaches [31].”
BackgroundHelge, J. W., Stallknecht, B. M., Drachmann, T., Hellgren, L. I., Jiménez-Jiménez, R., Andersen, J. L., Richelsen, B., & Bruun, J. M. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02180.x · Cited by 34
Skeletal muscle lipid flux: running water carries no poison
Funai, K., & Semenkovich, C. F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00152.2011 · Cited by 27 · cited 1×
“As Funai and Semekovich [29] beautifully put it, running water does not carry poison.”
BackgroundType 2 diabetes: multimodal treatment of a complex disease
Pournaras, D. J., & le Roux, C. W. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00132-4 · Cited by 22 · cited 1×
“It has been variously described as an epidemic or even as the plague [1] of the 21st century.”
BackgroundNewsom, S. A., Everett, A. C., Park, S., Pelt, D. W. V., Hinko, A., & Horowitz, J. F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120871 · Cited by 12
Cited by
Hong, S.-H., & Choi, K. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020494 · Cited by 390
“Activated macrophages release TNF-α, IL-1b, IL-6, and TGF-β, which stimulate myofibroblasts, increase collagen production, and decrease protease inhibitor secretion [121,122].”
BackgroundSergi, D., Naumovski, N., Heilbronn, L. K., Abeywardena, M., O’Callaghan, N., Lionetti, L., & Luscombe-Marsh, N. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00532 · Cited by 347
Self-citationA plant-based diet for the prevention and treatment of type 2 diabetes.
(2017) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2017.05.009 · Cited by 320
Role of Inflammatory Cytokines, Growth Factors and Adipokines in Adipogenesis and Insulin Resistance
Al-Mansoori, L., Al-Jaber, H., Prince, M. S., & Elrayess, M. A. (2022) · Inflammation · doi:10.1007/s10753-021-01559-z · Cited by 285
“These active lipid molecules enhance lipid accumulation and induce IR in a variety of target organs [28].”
BackgroundLivshits, G., & Kalinkovich, A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100980 · Cited by 237
Metadata
- Authors
- Kitessa, S., & Abeywardena, M.
- Affiliations
- South Australian Research and Development Institute (AU)
- CSIRO Health and Biosecurity (AU)
- Corresponding author
- Kitessa, Soressa
- ORCID
- Abeywardena, Mahinda
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2016-07-29
- Volume
- 8
- Issue
- 8
- Pages
- 466
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC4997379
- OpenAlex
- W2486838615
- Cited by
- 98
- References
- 75
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 7 · 2023: 9 · 2022: 10 · 2021: 9 · 2020: 7 · 2019: 11 · 2018: 19 · 2017: 8 · 2016: 3
- FWCI
- 1.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Commonwealth Scientific and Industrial Research Organisation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin resistance, skeletal muscle, intramyocellular lipid, lipid intermediates, ceramide, diacylglycerol, lipidomics, glucose homeostasis, type 2 diabetes
- MeSH terms
- Animals, Ceramides, Diglycerides, Humans, Insulin Resistance, Models, Biological, Prediabetic State, Muscle, Skeletal, Lipid Metabolism, Adipose Tissue, White, Metabolomics, Diet, High-Fat, Absorption, Physiological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.